• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 11
  3. Author

Online ISSN: 2515-8260

Volume7, Issue11

Serum Zinc and Magnesium Levels in Type 2 Diabetes Mellitus Patients on Metformin Therapy

    Shaik Anwar Hussain K , Kalai Selvi RAJENDIRAN , Monisha MOHAN, Lenin MUNISAMMY , Kuzhandai Velu VENGATAPATHY , Ananda Vayaravel CASSINADANE

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 609-616

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

In diabetes mellitus, the deficiency of trace elements is said to be linked to poor glycemic control and oxidative stress related complications. The deficiency of magnesium and zinc accelerate the disease and its complications. Our study assessed the correlation of serum magnesium and zinc levels with glycemic control in type 2 diabetes patients. Methods: This cross sectional study included 150 study participants. 76 type 2 diabetes patients were cases and 74 healthy participants were grouped to controls. Samples for fasting and postprandial blood glucose, HbA1c, magnesium and zinc were collected and analysed in a fully automated analyser. Data was analysed by Graph Pad Prism software. Results: Cases had higher levels of fasting, postprandial, HbA1c levels as compared to controls with p<0.0001. Cases had significant reduction in serum levels of zinc and magnesium. Zinc and magnesium showed a significant inverse correlation with glycemic control with r values of -0.56 and -0.48 respectively. Conclusion: Low serum magnesium and zinc levels can worsen the complications of disease. So, early detection of its deficiency and supplementation alleviates the disease progression.
Keywords:
  • PDF (302 K)
  • XML
(2020). Serum Zinc and Magnesium Levels in Type 2 Diabetes Mellitus Patients on Metformin Therapy. European Journal of Molecular & Clinical Medicine, 7(11), 609-616.
Shaik Anwar Hussain K , Kalai Selvi RAJENDIRAN , Monisha MOHAN, Lenin MUNISAMMY , Kuzhandai Velu VENGATAPATHY , Ananda Vayaravel CASSINADANE. "Serum Zinc and Magnesium Levels in Type 2 Diabetes Mellitus Patients on Metformin Therapy". European Journal of Molecular & Clinical Medicine, 7, 11, 2020, 609-616.
(2020). 'Serum Zinc and Magnesium Levels in Type 2 Diabetes Mellitus Patients on Metformin Therapy', European Journal of Molecular & Clinical Medicine, 7(11), pp. 609-616.
Serum Zinc and Magnesium Levels in Type 2 Diabetes Mellitus Patients on Metformin Therapy. European Journal of Molecular & Clinical Medicine, 2020; 7(11): 609-616.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 410
  • PDF Download: 389
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus